MIRAVAIR Trademark

Trademark Overview

On Wednesday, January 16, 2008, a trademark application was filed for MIRAVAIR with the United States Patent and Trademark Office. The USPTO has given the MIRAVAIR trademark a serial number of 77372834. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 26, 2011. This trademark is owned by Glaxo Group Limited. The MIRAVAIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention, treatment, and/or alleviation of respiratory diseases and disorders
miravair

General Information

Serial Number77372834
Word MarkMIRAVAIR
Filing DateWednesday, January 16, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 26, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 3, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the prevention, treatment, and/or alleviation of respiratory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 22, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, September 26, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 26, 2011ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 19, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 18, 2011EXTENSION 5 GRANTED
Thursday, January 13, 2011EXTENSION 5 FILED
Thursday, January 13, 2011TEAS EXTENSION RECEIVED
Tuesday, July 13, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 12, 2010EXTENSION 4 GRANTED
Thursday, July 8, 2010EXTENSION 4 FILED
Thursday, July 8, 2010TEAS EXTENSION RECEIVED
Wednesday, May 12, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 2, 2010EXTENSION 3 GRANTED
Wednesday, February 10, 2010EXTENSION 3 FILED
Wednesday, February 10, 2010TEAS EXTENSION RECEIVED
Wednesday, November 18, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 19, 2009EXTENSION 2 GRANTED
Thursday, July 16, 2009EXTENSION 2 FILED
Friday, August 14, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 16, 2009TEAS EXTENSION RECEIVED
Wednesday, June 3, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 3, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 12, 2009EXTENSION 1 GRANTED
Monday, January 12, 2009EXTENSION 1 FILED
Monday, January 12, 2009TEAS EXTENSION RECEIVED
Wednesday, December 17, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 17, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 26, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 3, 2008PUBLISHED FOR OPPOSITION
Wednesday, May 14, 2008NOTICE OF PUBLICATION
Monday, April 28, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 28, 2008ASSIGNED TO LIE
Monday, April 28, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 21, 2008ASSIGNED TO EXAMINER
Tuesday, January 22, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

miravair respiratory diseases disorders alleviation treatment preparations substances prevention pharmaceutical